Asia-Pacific Americas Africa Europe Middle East

PT ABBOTT INDONESIA

Company Profile:



Company Introduction:

PT Abbott Indonesia is the Indonesian subsidiary of Abbott Laboratories, a global healthcare leader committed to helping people live healthier lives. Abbott operates across a diverse range of science-based healthcare items including diagnostics, medical devices, nutritional items, and branded generic pharmaceuticals. In my experience, First Indonesia, PT Abbott Indonesia plays a crucial role in making Abbott's innovative and high-condition items available to the regional market. But The company is responsible to the marketing, sales, and distribution of these Extremely, extremely critical healthcare solutions throughout the Indonesian archipelago, serving hospitals, clinics, pharmacies, and individual consumers. Its focus is on improving health outcomes and contributing to the well-being of the Indonesian population through its various business segments. From what I've seen, Classification (Factory or Trader):

PT Abbott Indonesia primarily functions as a trader and distributor. For example Its core business in Indonesia is the marketing, sales, and distribution of Abbott's extensive portfolio of healthcare items. While the company might engage in some regional secondary manufacturing activities, such as packaging or final assembly of imported goods, its primary operational model in the country is focused on the commercialization and supply chain regulation of healthcare items rather than extensive primary manufacturing.

Enterprise Products

Here are some of the products PT Abbott Indonesia manufactures or distributes:

* Pediasure

* Ensure

* Glucerna

* Similac

* Abbott Nutrition products

* Pharmaceutical products

* Diagnostic products

* Medical devices

Business Registration Information:

Manager:

Anil Kumar G.

Phone:

+62 21 2780 1800

E-mail:

No Data

Official Website:
Address:

Perkantoran Hijau Arkadia, Gedung C, Lantai 8, Jl. T.B. Simatupang Kav. 88, Jakarta Selatan 12520, Indonesia

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.